Coherus Marks Exit From Biosimilars By Completing Udenyca Divestment

Accord BioPharma Takes Charge Of Pegfilgrastim Franchise In US

 
• By Dave Wallace
  
Coherus has exited the biosimilars arena (Shutterstock)

More from Deals

More from Strategy